US Bancorp’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-577
Closed -$5K 3791
2018
Q2
$5K Hold
577
﹤0.01% 3348
2018
Q1
$5K Hold
577
﹤0.01% 3347
2017
Q4
$5K Buy
+577
New +$4.29K ﹤0.01% 3345
2017
Q3
Sell
-322
Closed -$4K 3705
2017
Q2
$4K Buy
+322
New +$3.17K ﹤0.01% 3299
2017
Q1
Sell
-156
Closed -$1K 3697
2016
Q4
$1K Hold
156
﹤0.01% 3506
2016
Q3
$2K Sell
156
-347
-69% -$3.85K ﹤0.01% 3405
2016
Q2
$6K Buy
503
+47
+10% +$588 ﹤0.01% 3157
2016
Q1
$6K Buy
456
+190
+71% +$1.97K ﹤0.01% 3148
2015
Q4
$3K Buy
266
+27
+11% +$349 ﹤0.01% 3390
2015
Q3
$4K Buy
239
+163
+214% +$3.3K ﹤0.01% 3318
2015
Q2
$2K Hold
76
﹤0.01% 3454
2015
Q1
$2K Sell
76
-30
-28% -$609 ﹤0.01% 3469
2014
Q4
$2K Buy
+106
New +$2.1K ﹤0.01% 3441
2013
Q4
Sell
-23
Closed 3507
2013
Q3
$0 Hold
23
﹤0.01% 3383
2013
Q2
$0 Buy
+23
New +$275 ﹤0.01% 3254

US Bancorp's KND Position: Q3 2018 in Review

US Bancorp sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 577 shares — an estimated $5K sold.

US Bancorp first reported a position in KND in Q2 2013 and held it in 15 quarters. The position peaked at $6K in Q2 2016. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

  • US Bancorp reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
  • US Bancorp sold 577 Kindred Healthcare shares in Q3 2018, an estimated $5K.
  • US Bancorp first reported a position in Kindred Healthcare in Q2 2013 and held it in 15 quarters.
  • US Bancorp's Kindred Healthcare position peaked at $6K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on US Bancorp's 13F filing for Q3 2018, filed 1 Nov 2018.